BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Medilink Midlands - ECPv6.15.20//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Medilink Midlands
X-ORIGINAL-URL:https://staging.medilinkmidlands.com
X-WR-CALDESC:Events for Medilink Midlands
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20160327T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20161030T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20170326T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20171029T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20180325T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20181028T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20170713T080000
DTEND;TZID=Europe/London:20170713T183000
DTSTAMP:20260417T041244
CREATED:20171013T141433Z
LAST-MODIFIED:20171013T141433Z
UID:17668-1499932800-1499970600@staging.medilinkmidlands.com
SUMMARY:ON Helix
DESCRIPTION:One of the key issues described by many researchers is how to overcome the innovation gaps on the translational research pathway. This includes identifying barriers on which to concentrate\, finding funding and meeting the right networks. \nON Helix is a must-attend translational research conference for the life science industry and academia. This one day event aims to inform delegates of how to turn early stage inventions and ideas into innovative health treatments. It will present the UK landscape of the business environment\, funding\, scientific and clinical research excellence and will be a unique knowledge-sharing environment between academia and business. It will combine keynote presentations from high profile global leaders\, practical information\, exceptional world class case studies and plenty of space for networking. \nWhy should I attend? \nAs the largest membership organisation in Europe for the sector\, One Nucleus has very strong engagement with the life science and healthcare sector nationally and internationally so is perfectly placed to ensure the attendance and engagement of key stakeholders in translational research. The feedback both from our exceptional Advisory Board and widely throughout the business and academic community has been unanimously positive about this event – its concept\, objectives and the platform it will create. \nWho should attend? \n  \n\n\nBiotech and healthcare company senior executives\nAcademic technology transfer executives\nPharma business and research development directors\nLife science investors\nTechnical and professional service providers\nScientists working in translational research or medicine\n\nThe following key-note speakers have been announced: \n  \n\nSharon Vosmek\, CEO\, Astia\nDavid Tapolczay\, CEO\, MRC Technology\nSara-Jane Dunn\, Microsoft\n\nTo view further information including the full event programme\, delegate fees and how to regsiter\, please click here. \n*SPECIAL OFFER* Medilink members can receive a 10% off the standard ticket price; please contact us here for a discount code.
URL:https://staging.medilinkmidlands.com/event/on-helix/
LOCATION:Wellcome Genome Campus Conference Centre\, Hinxton\, Cambridge\, CB10 1SA
END:VEVENT
END:VCALENDAR